Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Mar 22, 2022 7:25pm
110 Views
Post# 34536147

RE:Business model problem here

RE:Business model problem hereProblem was the "old" business model was the "field of dreams". Then along came covid and wrecked it all; except ironically if it wasn't for covid Stage could be Tango Unform up by now.

The new model is extermely labour intensive, to scale up from here would require hundreds of people to do clerical work. Stage has become a small time low margin retail entity.

If I hear telehealth, spoke and hub or whatever the new delaying tactic is I am going to puke.

Directvoice wrote:

I realize that maybe the new business model that Stage now is promoting have a scale problem that the old model didn't have. The old model was to sale tests. It costs a lot to establish your test in the medicsl market at first but you could end up making money. 

The new model is to use telehealth to reach customer but you are limited by the number of staf and oncologist that you have.  Cheaper to start but limited...  

What do you think?



<< Previous
Bullboard Posts
Next >>